Tuesday, September 11, 2012

OVARIAN CANCER AWARNESS MONTH: Spread the word.

                        Linda at four.  Cute from the start.
Then she got cuter.

Suddenly I am neck-deep in important stuff to write about.  I haven’t even looked at the NCI Cancer Bulletin for September 4th, except to note from the “cover page” that it has lots of articles on the genome and cancer.  I am dipping my toe into an incredibly important info-dump (code name ENCODE) detailing a vast, coordinated set of new genome studies.  (36 separate papers from three different journals, all published on the same day.  One of the PIs here at the Hutch told me not to attempt to read the original papers; just read the press releases instead.  He has concerns for my mental health.)  There also is an article in the NY Times about new developments in the battle against lung cancer, which has important implications for using targeted therapy  for  many other kinds of cancer.  Again, this is genome-based.  However, because this is National Ovarian Cancer Awareness Month (you didn’t know that, did you?) – and because ovarian cancer is the disease I hate most in all the world – I am going to alert you to another NY Times* blurb, this one titled “Ovarian Cancer Screenings Are Not Effective, Panel Says”.  You can read it for yourself by going to http://nyti.ms/S4Jkiy.  It is easy going.
The gist is this:  The United States Preventive Services Task Force (the same group so hated and reviled by  urologists for their recommendation against using PSA to test for prostate cancer – see blog entry for 3/27/12, as well as having been stoned and run out of town for suggesting that women should not have mammograms before the age of 50) now says something that everybody agrees with:  you should not use currently available screening techniques on healthy women to detect ovarian cancer.  Current methodology consists of testing for the abundance of the protein CA-125 measured from a blood sample, followed by ultrasound.  CA-125  is well established as being  associated with ovarian cancer.  The problem here is that CA-125 can elevate for any number of reasons, not merely those that are scary.  Furthermore, ultrasound detects ovarian enlargements of all sorts, not all lethal.  A vast study shows conclusively that there is no gain in longevity from such screenings.  Moreover, of those screened about 10% received false positives, leading to unnecessary surgery.  The article states that this screening technique leads to about 20 surgeries for every cancer detected.  Too much needless pain, and too much expense – although the USPSTF always goes to great lengths to assure you that they don’t take expense into consideration.  Still, about 1/3 of doctors will recommend this screening, or not talk you out of it if you ask for it.  So, be warned.
Note that this applies only to healthy women.  If you have a family history or you are carrying a BRCA mutation, or if you experience the symptoms below, for God’s sake get screened.
·           *   *   *   *   *   *  
Ovarian Cancer Symptom Index
                Any new and persistent incidences of:
Bloating
Pelvic/abdominal pain
Trouble eating, or feeling full quickly
Urinary symptoms such as urgency or frequency

·           *   *   *   *   *   *  

This article also contains the usual disgusting statistics about the prevalence – and mortality – of ovarian cancer.  The American Cancer Society estimates that 22,280 new cases will be diagnosed this year in the U.S., and 15,500 women will die.  Like I’ve said many times before, ovarian cancer is  crying out to be wiped from the face of the earth.
By the way:  the article ends with the words “We’ve got to find something else” (referring to an early-warning screening protocol.)  That’s exactly what my group at the Hutch is working on.
*My wide-ranging reporter Dick Ingwall is to be thanked for alerting me to these NY Times articles.  Thanks, Dick.  Since he pays for and reads it, I am spared the effort and expense.  The only problem with reading these bits on-line is that you are always welcomed by Michelle Obama, who will invite you to dinner at the White House.  “Air fare will be provided!”  Now, how DO they manage that?

7 comments:

  1. Linda, from a real 'cutie pie' at four, grew up to become a beautiful woman, in all respects.

    Some comments on cancer to follow...

    ReplyDelete
    Replies
    1. Good. I look forward to what follows.

      Delete
    2. Check out another article in the NY Times - "Vets and Physicians Find Research Parallels", Sept. 9. 2012. Great discussion on the increasing collaboration of veterinary and medical researchers in a wide range of human/animal diseases. The article states there is a 'growing frustration with the inefficiency of using the rodent model in lab research, which often fails to translate to human subjects.' My thoughts: pet parents have to be given credit too for advocating for advancements in treatment/cures for their animals which has often shown benefits for human patients.

      Ask your FH colleagues what is the role, if any, of vitamin B12 in human/ovarian cancers. 'Cancer Research Made Equal' is an article in Catnip, newsletter for cat owners from the Cummings School of Veterinary Medicine at Tufts University (Sept. 2012) profiles veterinary investigator Annette Sysel, DVM, MS of the Bauer Research Foundation in Akron, OH. Dr. Sysel says her 'goal is to ensure that advances in cancer detection and treatment available to people and dogs are equally available to cats' The article states that cancer cells rely on B12 for growth and that they produce proteins that scavenge for that nutrient. Dr. Sysel says, 'Many tumors gobble up B12 like crazy'. She is conducting research on a new drug that is called nitrosylcobalamin, or NO-Cbl. This drug is made up of vitamin B12 bound to nitric oxide which is toxic to cancer cells. It kills the cancer cells from the inside out because the cells can't distinguish between the drug and normal B12 - referred to as a Trojan horse drug. Surrounding non-cancerous cells are spared because they don't have anywhere near the number of B12 receptors on their surfaces that cancer cells do. NO-Cbl is also being considered for treatment of a fatal type of brain tumor in people - glioblastoma multiforme.

      Regarding the work on genomes: are humans more/less genetically diverse (not the total number of genes)than any other animal group? Is that a reasonable question? Kristen, can you help me out?

      Delete
  2. Thanks Dad for all your research and translation of information into something I understand and have time to read! And you even make it entertaining. I read the Fred Hutch magazine, usually, but have not found the time to do much further research. I am really interested in the idea that diet and exercise can have such a big impact on disease suseptibility and control.
    And I love all the pictures of Linda.

    Linda K

    ReplyDelete
  3. You're welcome. Bully all your friends into reading it, too. My log, that is - as well as the Hutch mag.

    ReplyDelete
  4. Well, I have some things to say about this one. First of all, I have had CA-125 screenings for years due to family history of breast/ovarian cancer. I know going into it that this is not a reliable indicator of ovarian cancer. It is a SCREENING test, it points to people who may need further investigation. My attitude is, it's better than nothing. And other than ultrasound, which also is not reliable, the alternative right now IS nothing. I agree that we desperately need a reliable screening tool and am glad your group is working on it. I hope they find it. About a year ago my CA-125 was elevated due (most likely) to fibroids. Ultrasound showed the fibroids were causing problems, resulting in hysterectomy. So these screening tools can also be used to identify other problems, not just cancer. But I know you said healthy women shouldn't have it. But ovarian cancer hits all kinds of people so how do you know if you are healthy before you start having symptoms? I think people need to be educated about the test so they don't panic if they get a positive result. At least until something better comes along.

    Bunny, your stuff was very interesting. I just had a bird die of ovarian cancer. I love the idea of the molecular targets (like the B12 bound to nitric oxide) and know they've been trying to get this form of cancer treatment working for years in human cancers. I'm not sure if any of them actually do work yet. Anyone know? As for the genetic diversity of humans vs. other animals, I'm not sure. My understanding is they're pretty similar. Don't we share 99% of our genomes with chimps? Or something like that... I haven't studied genetics in a while, but maybe dad knows as a new genetics student.

    ReplyDelete
  5. Regarding your last few sentences- damned if I know. I heard that we share most of our genomes with coconut trees and lung fish, so being that close to chimps doesn't surprise me. Your point about monozygotic twins being exactly alike only at birth is a good one - I hadn't thought about it that way.

    ReplyDelete